This page includes the latest FDA filings for Relypsa Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
|---|---|---|
| Vifor Pharma, Inc. | Prescription Medication | 2024-10-04 |
| Vifor Pharma, Inc. | Prescription Medication | 2024-08-29 |
| Vifor Pharma, Inc. | Prescription Medication | 2024-08-16 |
| Vifor Pharma, Inc. | Prescription Medication | 2023-12-06 |
| Vifor Pharma, Inc. | Prescription Medication | 2023-04-11 |
| Vifor Pharma, Inc. | Prescription Medication | 2022-12-17 |
| Vifor Pharma, Inc. | Prescription Medication | 2022-01-06 |
| Vifor Pharma, Inc. | Prescription Medication | 2021-12-07 |
| Vifor Pharma, Inc. | Prescription Medication | 2021-05-29 |
| Vifor Pharma, Inc. | Prescription Medication | 2020-12-02 |
| Vifor Pharma, Inc. | Prescription Medication | 2019-12-27 |
| Vifor Pharma, Inc. | Prescription Medication | 2018-05-10 |
| Relypsa, Inc. | VELTASSA | 2015-10-23 |
| Relypsa, Inc. | VELTASSA | 2015-10-23 |
| Relypsa, Inc. | VELTASSA | 2015-10-23 |
RELYPSA INC | 0000-00-00 00:00:00 |
| NCAGE Code | 7GPD7 | RELYPSA, INC. |
| CAGE Code | 7GPD7 | RELYPSA, INC. |
| S.A.M. Registration | 7GPD7 [808446087] | RELYPSA, INC. |
| SEC | 0001416792 | Relypsa Inc |